Following DePuy Orthopaedics voluntary recall in August affecting hip replacement surgery patients, law firms experienced in both medical negligence and product liability litigation, such as The Padberg Corrigan firm, are very concerned for claimants who may be possibly leaving themselves vulnerable to unpaid medical bills and/or waiving other important legal rights.
On August 26, 2010, DePuy Orthopaedics, Inc. voluntarily recalled the ASR XL Acetabular System and DePuy ASR Hip Resurfacing System used in hip replacement surgery due to the large number of patients needing revision surgery or a second hip replacement medical procedure. According to data from the National Joint Registry of England and Wales, roughly one out of every eight recipients of the recalled devices, or about 12%-13%, had to undergo painful and expensive revision surgery within five years of the first procedure, when the surgery is typically intended to last 15 years. The metal on metal ball and socket device can create metal debris leading to inflammation and damage to muscles and soft tissues. It is estimated that about 93,000 people around the world have received one of the recalled implants.
The use of the device began in the U.S. in 2005. The FDA has received roughly 300 complaints by patients and doctors about the early failure of the system since 2008. The Australian Joint Registry had reportedly issued seven reports to DePuy, beginning in 2007, which identified problems with the ASR system. The system was withdrawn from the Australian market in 2009.
Of concern to the Padberg Corrigan Law Firm is the reimbursement procedures proposed by DePuy. Given the nature of the recall and the pain, expense and risks of revision surgery, it is highly recommended you contact a law firm qualified in medical negligence and product liability, such as Padberg Corrigan Law Firm, prior to agreeing to any compensation or settlement.